Reimbursed with a limitationOriginator productATC H02AB09

Plenadren

Plenadren is an originator product from Takeda Pharma AG and is listed on the FOPH Specialities List. Swiss mandatory health insurance therefore reimburses it within the authorised indication. The public price ranges from CHF 131.40 to CHF 284.95 depending on the pack; the patient co-payment is 10 per cent plus the deductible.

Core data

Authorisation holder
Takeda Pharma AG
ATC code
H02AB09
IT group
07.07.21 Cortisonum/Hydrocortisonum
Active substances
Hydrocortisonum
Preparation type
Originator product
On the SL since
01/03/2020
Last price change
01/06/2025
Co-payment
10%

Prices per pack

The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.

Plenadren Price table As of 17/09/2026
Dosage formPack sizeEx-factory pricePublic priceValid fromCat.GTIN
Ret Tabl 5 mgDs 50 StkCHF 105.72CHF 131.4001/06/2025B7680620680030
Ret Tabl 20 mgDs 50 StkCHF 246.91CHF 284.9501/06/2025B7680620680047

Limitation

This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.

The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.

FOPH wordingIndication 20070.01Valid from 01/06/2025

Nach Kostengutsprache durch den Krankenversicherer nach vorgängiger Konsultation und Genehmigung des Vertrauensarztes des Krankenversicherers zur Behandlung der primären Nebenniereninsuffizienz. PLENADREN wird zur Behandlung bei Patienten mit Nebenniereninsuffizienz eingesetzt, die unter optimaler herkömmlicher Hydrocortison Behandlung (mindestens 6 Monate) persistierende Leistungsinsuffizienz, Müdigkeit oder eine schlechte Lebensqualität aufweisen. Stellt der behandelnde Endokrinologe nach 6 Monaten keine Verbesserung fest, muss die PLENADREN Behandlung gestoppt werden.
Die Diagnose, die Verordnung und die Überwachung der Therapie mit PLENADREN darf ausschliesslich durch einen Facharzt der Endokrinologie/Diabetologie erfolgen, der an einem Spital mit einem Zentrum für Endokrinologie/Diabetologie tätig ist. Das Zentrum muss eine als FMH-Weiterbildungsstätte der Kategorie A oder B definierte Klinik für Endokrinologie/Diabetologie sein (https://www.siwf-register.ch).

More preparations in this group

FAQ

Is Plenadren covered by Swiss health insurance?

Yes, but only under conditions. Plenadren is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.

What does Plenadren cost in Switzerland?

The public price is the maximum price set by the FOPH and for Plenadren ranges from CHF 131.40 to CHF 284.95 per pack. The ex-factory price ranges from CHF 105.72 to CHF 246.91. Pharmacies may not charge more, but may charge less.

Correct or complete this entry

Market access

Do you need your product on the Specialities List?

Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.

  • Independent directory
  • Official FOPH data
  • Website in eight languages
Send an enquiry
Contact

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissreimbursement.com